Cristóbal Morales

Cristóbal Morales

unknown Spain

Cristóbal Morales is a member of the Spanish Society of Obesity and has commented on the broader systemic issues facing individuals with obesity in Spain, particularly how socioeconomic factors can severely impact their health outcomes and access to treatment.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
42,773
Power
1,281$
Sentiment
7.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Spain 1 7.00 0.09% +0% 46,754,778 42,698 $1,400,000 1,279$
Andorra 1 5.00 0.10% +0% 77,265 74 $3,000 3$
Totals 2 46,832,043 42,772 $1,403,000 1,282$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Andorra Andorra: Specialist Cristóbal Morales alerts that the powdered format of Mounjaro may not meet safety requirements. 5

Diari d’Andorra – major newspaper in the Principality: Venda il·legal d'un fàrmac per aprimar des d'Andorra cap a Espanya

Spain Spain: Cristóbal Morales is an endocrinologist who has participated in numerous studies on weight loss medications and emphasizes the complexity of obesity as a disease. 7

El País: La OMS reconoce los fármacos adelgazantes como esenciales para la humanidad: “Deben ser accesibles universalmente” | Salud y bienestar

Romania Romania: Cristóbal Morales is an endocrinologist who discusses the effectiveness of Orforglipron in weight loss. 8

Adevărul: Pastila revoluționară care ar putea înlocui Ozempic și Mounjaro: slăbești până la 20 kg în câteva luni fără injecții

Spain Spain: Cristóbal Morales, an endocrinologist at the Virgen Macarena University Hospital in Seville, states that these drugs are very safe and have been used for 20 years in diabetes. 8

El País: Pancreatitis, Ozempic y titulares exagerados: una alerta en el Reino Unido despierta dudas sobre el abuso del fármaco | Salud y bienestar

Spain Spain: Cristóbal Morales is an endocrinologist at the Virgen Macarena University Hospital in Seville. 7

El País: Llegan los nuevos fármacos antiobesidad que ya superan al Ozempic | Salud y bienestar